Every 12 minutes, an Australian dies from cardiovascular disease. Most never saw it coming.
CardiAction ProScreen and PreScreen are scientifically validated, non-invasive screening available through pharmacies and online. In just 20 minutes, with no blood test required, ProScreen identifies real-time arterial and heart health indicators that standard checks can miss, and delivers a personalised action plan individuals can start acting on immediately to reduce their risk. PreScreen is an online risk screen that goes beyond traditional risk factors by incorporating key validated biomarkers and a proprietary algorithm.
Australians lost to CVD each year
Global CVD deaths annually
Of CVD deaths preventable with early intervention
Time for a CardiAction ProScreen screening
The Detection Gap
Standard blood pressure checks are valuable. But they only tell part of the story.
Two people can have identical blood pressure readings on a standard arm-cuff check, yet completely different heart and artery health underneath. Central blood pressure, the pressure your heart, brain and kidneys actually experience, has been shown in multiple studies to be a stronger predictor of cardiovascular events like heart attack and stroke. That's what CardiAction measures.
people we screen have clinically relevant findings that a standard blood pressure check would miss entirely.
of all people screened had at least one result outside the CardiAction Target Range, prompting a conversation with their GP.
CardiAction does not replace your GP or existing screening pathways. It enhances them. CardiAction is an adjunct, not an alternative, to guideline-based cardiovascular prevention. It is an improved measurement and engagement service that helps people take the right next step earlier, typically GP follow-up and evidence-based care.
Reducing the Pressure on
Healthcare Systems
Our Drive
Empowering individuals and healthcare providers with scientifically grounded tools, offering a fresh and innovative approach to detecting and preventing cardiovascular disease related events such as heart attacks and strokes early. Our mission is to save lives and transform health outcomes, especially in underserved Indigenous and remote communities.
Our Destination
A world where cardiovascular disease is no longer the leading cause of preventable death. Achieved through accessible, accurate, and non-invasive health innovations like CardiAction, ensuring equitable reach to every community in need.
Two Solutions. One Mission.
CardiAction combines in-clinic precision with online accessibility to create a complete cardiovascular screening pathway.
ProScreen
In-Clinic Screening- In-clinic heart and artery health screening
- TGA-registered, FDA-cleared Pulse Wave Analysis device
- Direct measurement of central blood pressure and arterial stiffness
- Instant results with personalised action plan
PreScreen
Online Prediction- Online cardiovascular risk prediction
- Uses key biometrics — no blood test, no clinic visit
- Estimates central blood pressure and risk score
- Categorises risk as low, moderate, or elevated
PreScreen estimates. ProScreen measures. Together, a complete pathway.
Heart and artery health screening. Direct measurement. Real-time insight. Instant results with a personalised action plan.
CardiAction ProScreen is an in-person heart and artery health screening service delivered through trained screeners at participating pharmacies. Using a TGA-registered, FDA-cleared Pulse Wave Analysis device, ProScreen directly measures central systolic blood pressure, augmented pressure, arterial stiffness indicators, and other haemodynamic parameters from a standard arm cuff.
Central Blood Pressure
The pressure your heart and brain actually experience
Arterial Stiffness
Augmented pressure and central pulse pressure indicators
Heart Rate Assessment
Including irregular heartbeat detection
Instant Results
Personalised action plan you can implement straight away
The Empowerment Loop
The screening is not just about identifying concerns. It gives individuals a tailored action plan they can start acting on immediately. Individuals can then return for follow-up screenings to see the real impact of the changes they have made.
For Pharmacies
No setup cost: equipment, screener, marketing, and booking platform all provided
Revenue share on every screening
Increased foot traffic: customers actively seek out pharmacies offering ProScreen
Position your pharmacy as a leader in preventive health
Zero operational burden on pharmacy staff
Mass population cardiovascular risk screening. Online. Accessible. At scale.
CardiAction PreScreen is an online cardiovascular risk screening tool that can be deployed via any website or mobile application. Using self-reported biometrics, PreScreen estimates central systolic blood pressure and generates a preliminary cardiovascular risk score. Independently validated by Griffith University's Biostatistics Unit (R=0.785, P<0.001, 935 data points).
PreScreen estimates. ProScreen measures. Together, they create a scalable pathway from population screening to precision assessment.
Deployment Options
- • API integration
- • White-label
- • CardiAction mobile app
Target Sectors
- • Governments
- • Health insurers
- • Corporate wellness programs
- • Primary Health Networks (PHNs)
Built on 15 years of research. Grounded in peer-reviewed evidence.
Pulse Wave Analysis
The Uscom BP+ captures central haemodynamic parameters using suprasystolic oscillometry. Validated against invasive catheter measurement. TGA-registered. FDA-cleared.
Central Blood Pressure
Research in Hypertension (AHA) and the Journal of the American College of Cardiology demonstrates central blood pressure correlates more strongly with cardiovascular events than brachial readings.
PreScreen Validated
Independently validated by Griffith University with a correlation of R=0.785 (P<0.001) against actual clinical measurements across 935 data points.
Thousands screened. Lives changed. The evidence is in the data.
identified as moderate or elevated
with elevated findings referred to their GP
community engagement and satisfaction
pharmacy locations across Australia and New Zealand
Deployed through trusted healthcare partners
CardiAction Screening Australia
Delivering ProScreen heart and artery health screenings through pharmacies across Australia.
Health Screening NZ
Pioneering community-based cardiovascular screening across New Zealand with over 100 pharmacy locations.
Insights, research, and updates
Ready to bring CardiAction to your organisation?
Whether you are a pharmacy group, government health agency, health insurer, or clinical organisation, we welcome the opportunity to discuss how CardiAction can support your cardiovascular prevention strategy.